InvestorsHub Logo
Followers 0
Posts 119
Boards Moderated 0
Alias Born 04/06/2020

Re: None

Thursday, 11/24/2022 9:43:12 AM

Thursday, November 24, 2022 9:43:12 AM

Post# of 36589
NEWS: Revive Therapeutics Announces Update for Type C Meeting to Discuss Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

November 24, 2022 09:18 ET

https://www.globenewswire.com/news-release/2022/11/24/2562285/0/en/Revive-Therapeutics-Announces-Update-for-Type-C-Meeting-to-Discuss-Amended-Protocol-Agreement-of-Phase-3-Clinical-Study-for-Bucillamine-in-the-Treatment-of-COVID-19.html